Molbio Diagnostics Ltd is a point-of-care molecular diagnostics company focused on developing and commercialising rapid diagnostic technologies for infectious and non-communicable diseases. Its flagship Truenat platform is a portable, battery-operated PCR-based molecular diagnostic system designed for decentralised testing. The platform supports a broad range of diagnostic assays covering diseases such as tuberculosis, COVID-19, HIV, hepatitis and HPV. The company also offers diagnostic devices, test kits and solutions in digital pathology, radiology and breast-health screening. Its business model combines the sale or placement of diagnostic devices with recurring sales of proprietary single-use test kits and consumables. The recurring consumables component provides a scalable revenue model as the installed base of Truenat devices expands globally.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.
49 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.